医学
放射治疗
前列腺癌
挽救疗法
佐剂
外科
辅助放疗
抢救性手术
放射科
癌症
肿瘤科
内科学
化疗
作者
Giancarlo Marra,Francesco Barletta,Simone Scuderi,Gabriele Montefusco,Jonathan Olivier,Andres Affentranger,Josias Bastian Grogg,Thomas Hermanns,Luca Afferi,Christian D. Fankhauser,Agostino Mattei,Bartosz Małkiewicz,Alberto Bianchi,Alessandro Antonelli,Fabio Zattoni,Fabrizio Moro,Lieke Wever,Timo Soeterik,Roderick C.N. van den Bergh,Paweł Rajwa
标识
DOI:10.1097/ju.0000000000004468
摘要
To assess the survival outcomes of adjuvant radiation therapy (aRT) versus observation with or without early salvage RT (Obs±esRT) for cN0M0 pN1 PCa and to create a model for clinical decision making. We retrospectively identified 1,103 patients with cN0M0 PCa with pN1 PCa after surgery ( 2000-2021) at 18 referral centers. Kaplan-Meier curves, Cox proportional hazards were used. Overall, 670 (61%) had ISUP 4-5 and the median number of positive nodes was 1. On multivariable analyses, ≥3 positive nodes (HR 2.03,95% CI 1.22-3.37; p=0.006) and ISUP 5 (HR 1.92,95% CI 1.15-3.18; p=0.01) were associated with an increased all-cause mortality. Based on pT stage, ISUP and positive nodes, a two risk categories model was created. In men undergoing observation, seven years disease-free survival was 27% (95%CI 20.4-36) for low-intermediate and 11% (95%CI 6.7-17) for high risk patients; aRT had higher OS rates in the high-risk group (92%;95%CI 87-96 vs observation 84%, 95%CI 77-90; p=0.006). In interaction term analyses aRT confirmed its protective effect on mortality in high risk patients (HR 0.28, 95% CI 0.09-0.84, p=0.024). Results were comparable when excluding men with PSA persistence. In cN0M0 pN+ PCa, aRT yields a survival benefit compared to Obs±esRT only in men with a high risk disease based on unfavorable prognostic factors. We created a risk model to guide clinical decision making in this setting.
科研通智能强力驱动
Strongly Powered by AbleSci AI